Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference
Inspire Medical Systems (NYSE: INSP) management will present at the Stifel 2026 Healthcare Conference on November 10, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) management will present at the Stifel 2026 Healthcare Conference on November 10, 2026. The presentation is scheduled for 2:40 p.m. Eastern Time and will be webcast live. A replay will be available for two weeks afterward in the Event Archive section of Inspire’s investor website.
Details
Market move: INSP +7.61% in the Nov 4 session. Stifel conference presentation
On Nov 4, the first trading day after this news, INSP closed 7.61% above the previous close. Argus tracked a peak move of +4.5% during that session. Our momentum scanner recorded 16 alerts for this stock that day.
Data tracked by StockTitan Argus for the Nov 4 session.
Key Terms
obstructive sleep apnea medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Stifel 2026 Healthcare Conference on Tuesday, November 10, 2026.
Inspire is scheduled to present at 2:40 p.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor Contact
Brian Johnston or Louisa Smith
Gilmartin Group, LLC
IR@inspiresleep.com